Back
TG Therapeutics 10K Form
Sell
47
TGTX
TG Therapeutics
Last Price:
14.61
Seasonality Move:
7.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TGTX News And Ratings
See the #1 stock for the next 7 days that we like better than TGTX
TGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.79M |
|---|---|
| Cash Flow: | $-23.87M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.40 |
| Price / Book: | 37.1 |
Profitability
| EPS (TTM): | -1.46000 |
|---|---|
| Net Income (TTM): | $-198.34M |
| Gross Margin: | $2.52M |
| Return on Equity: | -142.56% |
| Return on Assets: | -73.69% |
TG Therapeutics Earnings Forecast
Key TG Therapeutics Financial Ratios
- The Gross Profit Margin over the past 25 years for TGTX is 90.32%.
- The Selling, General & Administrative Expenses for TGTX have been equal to 2,983.15% of Gross Profit Margin.
- The Research & Development expenses have been 4,019.00% of Revenue.
- The Interest Expense is -5.14% of Operating Income.
- The Net Earning history of TGTX is -7,108.96% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 13 years.
TG Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | TGTX |
| CUSIP: | 88322Q |
| Website: | tgtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 1.21 |
|---|---|
| Current Ratio: | 3.16 |
| Quick Ratio: | 3.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TGTX Technical Analysis vs Fundamental Analysis
Sell
47
TG Therapeutics (TGTX)
is a Sell
Is TG Therapeutics a Buy or a Sell?
-
TG Therapeutics stock is rated a Sell
The current TG Therapeutics [TGTX] share price is $14.85. The Score for TGTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.